CClinicalTrials.gg
RecruitingNCT03517072PRECOSUpdated May 22, 2026

Determinants of the Long-Term Success of Bariatric Surgery

An observational study in Morbid Obesity and Bariatric Surgery Candidate, sponsored by University Hospital, Lille. Recruiting at 4 sites in France. Per ClinicalTrials.gov, last updated 2026-05-22.

Sponsored by University Hospital, Lille · Observational

From the registry’s dates

  • Started Jul 2018; still recruiting 8 years 2 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,000
Sex
All
01

Study summary

The management of obesity is based on a multidisciplinary approach and justifies the use of surgery in patients with the most severe forms. Surgery for obesity or bariatric surgery generally allows rapid and significant weight loss however it is associated with significant risks, and its long-term results remain heterogeneous and unpredictable. Long-term data will clarify the role of different types of bariatric surgery in surgical strategy, improve patient information and identify predictors of failure in order to provide personalised and tailored surgery for each candidate .

Read the detailed description

Currently, there is insufficient data to determine the persistence over time of the positive results of bariatric surgery on weight loss. Moreover, there is no consensus or criteria for choosing one surgical weight loss procedure over another. The best choice for one patient may not be the most appropriate for another.

The results of this project will allow to better select obese patients likely to benefit from bariatric surgery, and to further personalise the management of severe obesity.

02

Conditions studied

  • Morbid Obesity
  • Bariatric Surgery Candidate

Browse trials for

03

In context

Obesity, Morbid

922 studies on the registry are indexed under Obesity, Morbid; 172 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 78 across 306 observational studies indexed under Obesity, Morbid.

Browse Obesity, Morbid studies →

Lead sponsor

University Hospital, Lille is the lead sponsor of 625 studies on the registry; 141 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The project relies on the network of Specialised Centres for the Management of Severe Obesity (Lille, Arras, Boulogne, Valenciennes).

Patients with severe obesity who underwent bariatric surgery 5 years ago will be included in each of the centre, during the usual multidisciplinary care visit.

Inclusion criteria

  • Patients who received bariatric surgery 5 years ago.

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate in the study,
  • Unable to receive informed information,
  • Unable to participate in the study
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Success rate in terms of weight loss

    Rate of patients who lost at least 20 of their initial body weight

    Time frame: at 5 years after bariatric surgery

Secondary outcomes

  1. Success rate in terms of weight loss according to type of bariatric surgery

    Rate of patients who lost at least 20 of their initial body weight at 1 year according to type of bariatric surgery (Gastric by-pass in Y or Omega, sleeve gastrectomy, and gastric band)

    Time frame: at 1 year after bariatric surgery

  2. Success rate in terms of weight loss according to type of bariatric surgery

    Rate of patients who lost at least 20 of their initial body weight at 5 years according to type of bariatric surgery (Gastric by-pass in Y or Omega, sleeve gastrectomy, and gastric band)

    Time frame: at 5 years after bariatric surgery

  3. Rate of re- interventions related to bariatric surgery

    Evaluation of re-interventions following bariatric surgery

    Time frame: 5 years

  4. Lost rate seen

    Evaluation of lost to follow-up

    Time frame: at 5 years after bariatric surgery

07

Study locations

4 of 4 sites recruiting
  • CH ARRAS
    Arras, France
    Recruiting
  • Ch Boulogne-Sur-Mer
    Boulogne-sur-Mer, France
    • · Contact · 0321993333
    Recruiting
  • Hôpital Claude Huriez, CHU
    Lille, France
    • François Pattou, MD,PhD · Principal investigator
    Recruiting
  • Ch de Valenciennes
    Valenciennes, France
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03517072
Lead sponsor
University Hospital, Lille
Responsible party
Sponsor
First posted
May 7, 2018
Start date
Jul 31, 2018
Primary completion
Jan 2027 (estimated)
Completion
Jan 2027 (estimated)
Last update
May 22, 2026

Study contacts

François PATTOU, MD,PhD
Contact
françois.pattou@chru-lille.fr
3 20 44 42 73 ext. +33
Violetta RAVERDY, MD,PhD
Contact
vraverdi@univ-lille.fr
3 20 44 42 73 ext. +33
François PATTOU, MD,PhD
principal investigator · University Hospital, Lille

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion